Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

extrapulmonary tuberculosis - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

extrapulmonary tuberculosis

MONDO:0000368

Find Clinical TrialsTrials

Overview

A tuberculosis that occurs at body sites other than the lung.

Treatments1 FDA approved

Clinical Trials4 registered · 3 recruiting

Diagnosis

Biomarker and diagnostic research for extrapulmonary tuberculosis has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

1 FDA-approved treatment is available for extrapulmonary tuberculosis, including PRETOMANID (PRETOMANID, approved 2019).

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

4 clinical trials registered, 3 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE3, 1 PHASE1. Research is primarily sponsored by academic and government institutions.

200 publications have been identified in PubMed for extrapulmonary tuberculosis. Research spans Case Report / Case Series (28%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (19%).

Research Type	Count	% of Total
Patient case studies	47

Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 6:39 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→What are the benefits and potential side effects of PRETOMANID for managing extrapulmonary tuberculosis?
→Are any of the 4 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

extrapulmonary tuberculosis

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications